Literature DB >> 12147222

Modulation of the expression of membrane-bound CD54 (mCD54) and soluble form of CD54 (sCD54) in endothelial cells by glucosyl transferase inhibitor: possible role of ceramide for the shedding of mCD54.

Atsushi Kawakami1, Ayumi Hida, Satoshi Yamasaki, Taiichiro Miyashita, Koto Nakashima, Fumiko Tanaka, Hiroaki Ida, Masako Furuyama, Kiyoshi Migita, Tomoki Origuchi, Katsumi Eguchi.   

Abstract

1-Phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) is a synthetic inhibitor toward glucosyl transferase. Here, we showed the functional role of sphingolipids on CD54 expression of endothelial cells (ECs) by the use of PDMP. CD54 mRNA expression in human umbilical vein endothelial cells (HUVECs) was not changed by PDMP; however, PDMP treatment significantly enhanced the expression of membrane-bound CD54 (mCD54) on HUVECs. In contrast, the amount of soluble form of CD54 (sCD54) in the culture supernatants of HUVECs was diminished by PDMP. Similar results were obtained when HUVECs were incubated with metalloproteinase inhibitor, KB-R8301, or in the presence of C2-ceramide. The above effect of PDMP, KB-R8301, and C2-ceramide in HUVECs was commonly found in unstimulated, TNF-alpha-stimulated, and IL-1beta-stimulated HUVECs. These data provide the possibility that the shedding of mCD54 into sCD54 by metalloproteinase-like enzyme is inhibited by PDMP, in which PDMP-induced accumulation of ceramide may act as a second messenger.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147222     DOI: 10.1016/s0006-291x(02)00829-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Effects of Microvesicles Derived from NK Cells Stimulated with IL-1β on the Phenotype and Functional Activity of Endothelial Cells.

Authors:  Kseniia Markova; Valentina Mikhailova; Yulia Milyutina; Andrey Korenevsky; Anastasia Sirotskaya; Veronika Rodygina; Elizaveta Tyshchuk; Polina Grebenkina; Andrey Simbirtsev; Sergey Selkov; Dmitry Sokolov
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.